Schwinn DA, Duke JB

Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 71-75
Archivo PDF: 92.09 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1— Brandt A, Schleithoff L, Jurkat-Rott K, Klinger W, Baur C, Lehmann-Horn F. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test. Hum Mol Genet 1999;8: 2055-2062.

2. 2— Heusch G, Erbel R, Siffert W. Genetic determinants of coronary vasomotor tone in humans. Am J Physiol: Heart Circ Physiol 2001;281:H1465-1468.

3. 3— Kalow W. Pharmacogenetics in biological perspective. Pharmacol Rev 1997;49:369-379.

4. 4— Liggett SB. Beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 2000;161:S197-201.

5. 5— Liggett SB. Pharmacogenetic applications of the Human Genome project. Nat Med 2001;7:281-283.

6. 6— Mathew JP, Rinder CS, Howe JG, Fontes M, Crouch J, Newman MF, Philips-Bute B, Smith BR. Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Ann Thorac Surg 2001;71:663-666

7. 7— McCarthy JJ, Hilfiker R. The use of single nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 2000;18:505-508.

8. 8— Rathz DA, Gregory KN, Fang Y, Brown KM, Liggett SB. Hierarchy of polymorphic variation and desensitization permutations relative to beta-1 and beta-2 adrenergic signaling. J Biol Chem 2003;278:10784-10789.

9. 9— Risch N, Merikangas K. Science 1996;273:1516-1517.

10. 10— Rockman HA, Koch WJ, Lefkowitz RJ. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am J Physiol 1997;272:H1553-1559-

11. 11— Rogers JF, Nafziger AN, Bertino JS Jr. Pharmacogenetics affects dosing efficacy and toxicity of cytochrome P450-metabolized drugs. Am J Med 2002;113:746-750.

12. 12— Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000;405:857-865.

13. 13— Schwinn DA, Booth JV. Genetics infuses new life into human physiology: implications of the human genome project for anesthesiology and perioperative medicine. Anesthesiology 2002;96: 261-263.

14. 14— Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nature Rev (Genetics) 2002;3:1-7.

15. 15— Weinshilboum R. Inheritance and drug response. N Engl J Med 2003;348:529-537.

16. 16— Ziegeler S, Tsusaki BE, Collard CD. Influence of genotype on perioperative risk and outcome. Anesthesiology 2003;99:212-219.